EnteroMedics of St. Paul, MN received the European CE Mark of approval for its second generation Maestro RC System. By intermittently blocking vagus nerve trunks using electronic pulses (VBLOC therapy), the Maestro RC helps relieve the sensation of hunger and hopefully aid patients trying to control their weight.
The Maestro RC System, a pacemaker-like device, offers a patient-oriented obesity therapy that affects the physiology of hunger and fullness without forcing punitive, mechanical limits to lifestyle and diet, or requiring surgical alteration of the anatomy.
EnteroMedics also announced that the Company’s pivotal ReCharge Trial remains on track, with patient enrollment and implants beginning in the first half of 2011 and enrollment completion anticipated by the end of 2011. The ReCharge Trial is a pivotal clinical trial evaluating the safety and efficacy of VBLOC therapy delivered via the Maestro RC System in the treatment of obesity.
Press release: EnteroMedics Receives CE Mark Certification for the Maestro RC System, Allowing Australian Regulatory Application to Move Forward
Flashbacks: EnteroMedics Presents Updated VBLOC Trial Data; European Union Clears VBLOC Vagal Nerve Blocking Therapy for Obesity Control; Vagal Electrical Nerve Stimulation Helps With Weight Loss in Clinical Trial; Vagal BLocking for Obesity Control